Search Login Register

Antithrombin III Deficiency Summary

Description: An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.

Also Known As: Antithrombin 3 Deficiency; Deficiency, Antithrombin III; Antithrombin 3 Deficiencies; Antithrombin III Deficiencies; Deficiencies, Antithrombin 3 Show All >>

Networked: 265 relevant articles (4 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Antithrombin III Deficiency

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antithrombin III : 2 outcomes 4 studies in 50 results : IBA
  2. Heparin (Liquaemin) : 1 outcome 2 studies in 47 results : FDA 74 Generic
  3. argatroban (MPQA) : 1 outcome 1 study in 4 results : FDA 3
  4. Ancrod (Arvin) : 1 outcome in 1 result : IBA
  5. Protein C : 6 studies in 65 results : IBA
  6. Protein S : 3 studies in 48 results : IBA
  7. factor V Leiden : 3 studies in 40 results : IBA
  8. Prothrombin (Factor II) : 1 study in 34 results : IBA
  9. Anticardiolipin Antibodies : 1 study in 10 results : IBA
  10. Thrombin : 1 study in 10 results : FDA 2
Show All >>

Diseases Related to Antithrombin III Deficiency

  1. Thrombosis (Thrombus)
  2. Thrombocytopenia (Thrombopenia)
  3. Protein S Deficiency (Deficiency, Protein S)
  4. Thrombophilia
  5. Protein C Deficiency
Show All >>

Key Therapies for Antithrombin III Deficiency

Efficacy Chart >>
  1. Cardiopulmonary Bypass (Heart-Lung Bypass) : 1 outcome in 4 results
  2. Critical Care : 1 study in 1 result
  3. Transplants (Transplant) : 6 results
  4. Renal Dialysis (Hemodialysis) : 4 results
  5. Catheters : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.